Inhibitor Therapeutics, Inc. (INTI)

Inhibitor Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-3.03	12.11	-0.31	-1.06	-2.72
Share-Based Compensation	0.01	0	0.04	0.23	0.27
Other Operating Activities	0.31	-0.37	0.06	0	-0.26
Operating Cash Flow	-2.7	11.74	-0.22	-0.83	-2.71
Dividends Paid	0	0	0	0	-0.1
Common Stock Issued	0	0	0.2	0.2	0.1
Share Repurchases	0	0	-0.18	-0.1	0
Other Financing Activities	-0.41	0.18	-0.2	-0.2	2.4
Financing Cash Flow	-0.41	0.18	0.18	0.1	2.4
Net Cash Flow	-3.11	11.92	-0.04	-0.73	-0.3
Free Cash Flow	-2.7	11.74	-0.22	-0.83	-2.71
Free Cash Flow Per Share	-0.02	0.03	-0.00	-0.00	-0.01

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.